Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism SRC inhibitors(Tyrosine-protein kinase SRC inhibitors), VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists), YES1 inhibitors(Yes tyrosine protein kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Discovery | US | - |